Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @LDyrskjot
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @LDyrskjot
-
Lars Dyrskjøt proslijedio/la je Tweet
Today at the
#phdday at Health@AarhusUni I have presented my PhD project at a poster session
#CancerResearch#SingleCell@moma_dkpic.twitter.com/aqWkyrJK9P
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Are Molecular Markers for Bladder Cancer Ready for Prime Time? https://dailynews.ascopubs.org/do/10.1200/ADN.19.190486/full/?cid=DM4277&bid=34737898#.XiTDJkc1epA.twitter …
@UroDocAshHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lars Dyrskjøt proslijedio/la je Tweet
Our most recent piece on "Prevalence of Pathogenic Germline Cancer Risk Variants in High-Risk Urothelial Carcinoma" in
@GIMJournal. Thankful to my amazing colleagues and mentors.@DanaFarber@BrighamWomens@BrighamResearch. Tweetorial below! https://www.nature.com/articles/s41436-019-0720-x.pdf …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lars Dyrskjøt proslijedio/la je Tweet
Pathologic germline variants found in 14% of
#bladdercancer pts@sloan_kettering Younger pts at even higher risk (22%) ! Strong data to support regular germline testing particularly younger patients. https://doi.org/10.1200/JCO.19.01395 …@UroOnc@UrologyMSK@AmerUrologicalHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Stormøde i Nationalt Genom Center vedr udvælgelse af patientgrupper til helgenomsekventering.
@ulassen fortæller om fordele ved analyser af metastatisk cancer.pic.twitter.com/5qEAXSPEBQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lars Dyrskjøt proslijedio/la je Tweet
Er du den kommende videnskabelig koordinator i det nye Nationale Danske Forskningscenter for Cirkulerende Tumor DNA? Se stillingsopslag her:https://health.au.dk/om-health/ledige-stillinger/job/videnskabelig-koordinator-til-det-nye-nationale-danske-forskningscenter-for-cirkulerende-tumor-dna-g/ …
@AarhusUni@AUHdk@moma_dk@DCCCcancer@cancer_dkHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lars Dyrskjøt proslijedio/la je Tweet
Check out latest work from the Lund Bladder Cancer Group on molecular changes in in
#bladdercancer patients with multiple recurrences and disease progression. Open access now available@IJC Tweetorial ahead!https://doi.org/10.1002/ijc.32737 …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Diskussion af strategier til kræft-DNA guided behandling på vores 2. ctDNA DCCC netværksmøde i Odense.
@DCCCcancer@cancer_dk@ClausLindbjergpic.twitter.com/Dc9H6Z50zC
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
I look forward to attend
#EMUC19 in Vienna on Friday and discuss urinary biomarkers in NMIBC - hope to see friends and colleagues there!https://twitter.com/EAU_Uroonco/status/1193423159246102533 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lars Dyrskjøt proslijedio/la je Tweet
happy to see paper published with awesome
@AbhiTrip87 ‘editorializing’ on NGS role in urothelial Ca! Glad to comment on excellent data by colleagues.@neerajaiims@sonpavde@ResearchWyatt@montypal@LDyrskjot@HsiehLab@OncoAlert@lalaniMD@PBarataMDhttps://www.eu-focus.europeanurology.com/article/S2405-4569(19)30274-3/fulltext …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lars Dyrskjøt proslijedio/la je Tweet
MOMA søger to molekylærbiologer (eller lignende) til den diagnostiske NGS-enhed på Aarhus Universitetshospital. Ansøgningsfrist 18.11.2019 https://rm.emply.net/recruitment/vacancyAd.aspx?publishingId=b476bb0d-1b5d-47f1-9fc1-60d833a94fdf …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lars Dyrskjøt proslijedio/la je Tweet
Sequential tissue analysis after neoadjuvant atezolizumab shows dynamic changes with therapy. Baseline activated T cells predict response. Up regulation of fibroblast (FAP) and cell cycle genes predict resistance. TMB and PD-L1 seem less relevanthttps://www.nature.com/articles/s41591-019-0628-7 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Great news -
@cancer_dk has granted funding to establish a new national research center for circulating tumor DNA guided cancer management - we are looking forward to getting started!@DCCCcancer@ClausLindbjerg@GarmLise@AUHdk@AarhusUnihttps://twitter.com/cancer_dk/status/1188762932680810496?s=20 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lars Dyrskjøt proslijedio/la je Tweet
Nu kan forskerne gå i gang
25 mio. kr. fra #knækcancer går til nationalt forskningscenter for behandling vejledt af kræft-DNA i blodet#forskning#dkforsk#kræft#sundpol@ClausLindbjerg@LDyrskjot@AUHdk@DCCCcancerhttps://www.cancer.dk/nyheder/25-mio-kr-fra-knaek-cancer-gaar-til-forskningscenter-for-kraeft-dna-i-blodet/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lars Dyrskjøt proslijedio/la je Tweet
Two-year, bioinformatics postdoc position on evolution of germline mutation processes available in my group at Aarhus University now. For details and application see http://tinyurl.com/yy2el3hb . Deadline October 31. Please RT.
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lars Dyrskjøt proslijedio/la je Tweet
Se med på mandag 21.10. kl 8.30 når TV2 Go' Morgen Danmark sender live fra MOMA
@moma_dk i anledning af@KnaekCancer ugen. Prof.@ClausLindbjerg interviewes om det planlagte nationale forskningscenter for behandling vejledt af kræft-DNA i blodet. https://bit.ly/32utPxX pic.twitter.com/zT3NQsoNva
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lars Dyrskjøt proslijedio/la je Tweet
@SwantonLab latest#TRACERx paper now online with@NatureMedicine! ORACLE GE signature utilise clonal expression to identify poor outcome NSCLC patients. Congrats to Dhruva on his beautiful first author publication! Find it here: https://rdcu.be/bTqIeHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lars Dyrskjøt proslijedio/la je Tweet
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
@Roland3097@OncoBellmunt@Uromigos@pcvblack#VisualAbstract#bladdercancer https://www.europeanurology.com/article/S0302-2838(19)30695-5/fulltext …pic.twitter.com/aHYt3PKnli
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lars Dyrskjøt proslijedio/la je Tweet
#IBCN2019 in Aarhus, Denmark was a success. Thank you to those who travelled far and wide! We welcome our new members! Safe travels and see everyone at#IBCN2020 in Montreal, Canada@WesKassouf!@UroDocAsh@pcvblack@GoebellJ@SWilliams_MD@Roland3097@ttodenhoefer@LDyrskjotpic.twitter.com/lTZmL1z9fX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.